MarketLens
Sign Up

Is Genflow Biosciences on the Cusp of a Longevity Breakthrough

4 months ago
SHARE THIS ON:

Is Genflow Biosciences on the Cusp of a Longevity Breakthrough

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Beyond Cellular Models: Longevica Capitalizes on World's Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline

Longevica formed a scientific advisory board to convert its $13M, 16,000-subject in vivo longevity study into AI-driven drug discovery, pet health, and human therapies. The move aims to unlock a human...
News•2 months ago

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

Colossal Biosciences founder Ben Lamm said the woolly mammoth could be brought back within a few years, citing the company's genetic research efforts. The timeline signals progress in de-extinction te...
Stock News•3 months ago

Healome Therapeutics cierra una ronda de financiación de 2 millones de libras liderada por Empirical Ventures

Healome Therapeutics closed a £2M funding round led by Empirical Ventures, after spinning out from the University of Birmingham to develop its patented matrix technology.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Farkas Says Starlink Slowdown Helped the Russians

Stock News•1 hour ago

Amazon (AMZN) Suffers a Larger Drop Than the General Market: Key Insights

Stock News•1 hour ago

Here's Why Dell Technologies (DELL) Fell More Than Broader Market

Stock News•1 hour ago

Microsoft (MSFT) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Elon Musk's Tesla eyes transportation ‘domination' as Cybercab expansion heats up competition with Waymo